Holen Sie sich die Stockscreener-App
2.42
0.41%
-0.01
Handel nachbörslich:
2.40
-0.02
-0.83%
Schlusskurs vom Vortag:
$2.43
Offen:
$2.4
24-Stunden-Volumen:
80,723
Relative Volume:
0.03
Marktkapitalisierung:
$3.28M
Einnahmen:
$9.81M
Nettoeinkommen (Verlust:
$-26.16M
KGV:
-0.0624
EPS:
-38.77
Netto-Cashflow:
$-17.45M
1W Leistung:
-1.63%
1M Leistung:
-43.85%
6M Leistung:
-97.88%
1J Leistung:
-99.13%
1-Tages-Spanne:
$2.383
$2.46
1-Wochen-Bereich:
$2.36
$2.59
52-Wochen-Spanne:
$2.23
$414.99
Reshape Lifesciences Inc Stock (RSLS) Company Profile
Firmenname
Reshape Lifesciences Inc
Sektor
Branche
Telefon
949-429-6680
Adresse
1001 CALLE AMANECER, SAN CLEMENTE
Vergleichen Sie RSLS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RSLS
Reshape Lifesciences Inc
|
2.42 | 3.28M | 9.81M | -26.16M | -17.45M | -38.77 |
|
ABT
Abbott Laboratories
|
134.11 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.63 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
391.81 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.28 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.02 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Reshape Lifesciences Inc Aktie (RSLS) Neueste Nachrichten
ReShape Lifesciences boosts stockholders’ equity above Nasdaq minimum - Investing.com
ReShape Lifesciences Raises Equity to Avoid Delisting - TipRanks
ReShape Lifesciences Stock Soars On Distribution Agreement With Recon Supply, Draws Retail Applause - MSN
Reshape Lifesciences Stock Price, Quotes and Forecasts | NASDAQ:RSLS - Benzinga
ReShape Lifesciences signs distribution deal with Recon Supply By Investing.com - Investing.com Canada
ReShape Lifesciences (RSLS) Stock Skyrockets Over 30% in Highly Volatile Session - Daily Chhattisgarh News
ReShape Lifesciences (RSLS) Signs Exclusive U.S. Distribution Deal | RSLS Stock News - GuruFocus
ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets - GlobeNewswire
ReShape Secures Exclusive Distribution Rights to 18M Veteran Healthcare Market with Recon Supply Deal - Stock Titan
Global Weight-Loss Devices Market: Top Devices, Growth Factors - openPR.com
ReShape Lifesciences Stock Slumps As Company Prices Public Offering At Significant Discount: Retail Holds On To Optimism - Asianet Newsable
ReShape Lifesciences Stock Slumps As Company Prices Public Offering At Significant Discount: Retail Holds On To Optimism By Stocktwits - Investing.com India
ReShape Lifesciences Prices $2.6 Million Share Offering - marketscreener.com
Crude Oil Moves Higher; Graham Shares Surge After Q4 Results - Benzinga
ReShape Lifesciences Announces Public Offering Pricing - TipRanks
ReShape Lifesciences prices public stock offering By Investing.com - Investing.com South Africa
ReShape Lifesciences prices public stock offering - Investing.com
SEC Form 424B5 filed by ReShape Lifesciences Inc. - Quantisnow
ReShape Lifesciences sets share price at $2.50 in public offering By Investing.com - Investing.com Canada
ReShape Lifesciences (RSLS) Announces Public Offering Pricing | - GuruFocus
Why Is ReShape Lifesciences Stock (RSLS) Down 45% Today? - TipRanks
ReShape Lifesciences (RSLS) Announces Public Offering Pricing | RSLS Stock News - GuruFocus
ReShape Lifesciences® Announces Pricing of Public Offering of Common Stock Raising Approximately $2.6 Million - Nasdaq
ReShape Lifesciences® Announces Pricing of $2.6 Million Public Offering - GlobeNewswire
ReShape Lifesciences Prices 1M Share Public Offering at $2.50 Per Share, Raising $2.6M for Weight Loss Solutions - Stock Titan
Reshape Lifesciences Stock Slumps As Company Prices Public Offering At Significant Discount: Retail Holds On To Optimism - MENAFN.com
Small Cap Stocks To Keep An Eye OnJune 3rd - MarketBeat
SEC Form 424B3 filed by ReShape Lifesciences Inc. - Quantisnow
ReShape Lifesciences achieves EU and UK medical device certification By Investing.com - Investing.com South Africa
ReShape Lifesciences And Kiora Pharma Impress Investors, Dollar General Uplifts Outlook - Finimize
ReShape Lifesciences Stock Soars On Regulatory Certification For Medical Devices In EU, UK: Retail Eyes Fair Valuation - Asianet Newsable
Why ReShape Lifesciences Stock Is Soaring Today: Key Drivers Behind Weight-Loss Company's Surge - Benzinga
ReShape Lifesciences Receives EU Certification for Product Portfolio; Shares Jump - marketscreener.com
ReShape Lifesciences Stock Soars On Regulatory Certification For Medical Devices In EU, UK: Retail Eyes Fair Valuation By Stocktwits - Investing.com India
ReShape Lifesciences (RSLS) Stock Skyrockets Over 62% in Morning Trading Frenzy - Daily Chhattisgarh News
ReShape Lifesciences (RSLS) Achieves Key European and UK Certifications | RSLS Stock News - GuruFocus
ReShape Lifesciences® Announces EU MDR Certification for Entire European and United Kingdom Product Portfolio - The Manila Times
ReShape Lifesciences Achieves EU MDR and UKCA Certification for Medical Devices, Enhancing Patient Safety and Market Access in Europe - Nasdaq
ReShape Lifesciences achieves EU and UK medical device certification - Investing.com
ReShape Lifesciences Beats 2027 Deadline: Gains Crucial EU MDR Certification While Others Still Wait - Stock Titan
RSLS stock touches 52-week low at $4.03 amid market challenges By Investing.com - Investing.com South Africa
RSLS stock touches 52-week low at $4.03 amid market challenges - Investing.com India
ReShape Lifesciences Faces Nasdaq Delisting Notice - TipRanks
ReShape Lifesciences Announces Equity Distribution Agreement - TipRanks
ReShape Lifesciences announces merger progress By Investing.com - Investing.com South Africa
ReShape Lifesciences Announces Merger with Vyome Therapeutics - TipRanks
ReShape Lifesciences announces merger progress - Investing.com
ReShape Lifesciences (NASDAQ:RSLS) Raised to Hold at Wall Street Zen - Defense World
ReShape Lifesciences® Reports First Quarter Ended March 31, 2025 Financial Results and Provides Corporate Update - GlobeNewswire
RSLS stock touches 52-week low at $5.5 amid market challenges - Investing.com
ReShape Lifesciences reports Q1 EPS $18.98 vs. ($135.37) last year - TipRanks
Finanzdaten der Reshape Lifesciences Inc-Aktie (RSLS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.54%
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):